Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...

In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...

San Francisco, USA & Zurich, Switzerland. April 23, 2024. Today Benchling announced that Zealand Pharma A/S, (“Zealand”) a biotechnology company focused on the discovery and development of ...

Benchling has seen its business grow at a healthy lick since it launched in 2012 with a mission to improve the efficiency of the biopharma R&D process, but it looks like it may be affected by the ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

Nearly half (44%) of top 50 biopharma companies are now involved in RNA work sparking new demand for tools purpose built for the full spectrum of RNA R&D Following the successful deployment of RNA ...

Benchling, which makes cloud R&D software for life sciences companies, boomed during the pandemic. It just hit 1000 customers and hired new execs from companies like Atlassian, Workday, and Zendesk.